Özge Cengiz Mat
No ORCID on file
· 1 paper in corpus
· active 2025
Study types
- article 1
Frequent coauthors
article
2025
Fulvestrant and bazedoxifene may reduce OHSS severity by lowering ascites formation and weight gain. These agents could be potential therapeutic candidates for OHSS with appropriate timing and dosage.